Literature DB >> 8316295

Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1.

J H Brown1, T S Jardetzky, J C Gorga, L J Stern, R G Urban, J L Strominger, D C Wiley.   

Abstract

The three-dimensional structure of the class II histocompatibility glycoprotein HLA-DR1 from human B-cell membranes has been determined by X-ray crystallography and is similar to that of class I HLA. Peptides are bound in an extended conformation that projects from both ends of an 'open-ended' antigen-binding groove. A prominent non-polar pocket into which an 'anchoring' peptide side chain fits is near one end of the binding groove. A dimer of the class II alpha beta heterodimers is seen in the crystal forms of HLA-DR1, suggesting class II HLA dimerization as a mechanism for initiating the cytoplasmic signalling events in T-cell activation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8316295     DOI: 10.1038/364033a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  543 in total

1.  HLA-DR and -DQ phenotypes in inflammatory bowel disease: a meta-analysis.

Authors:  P C Stokkers; P H Reitsma; G N Tytgat; S J van Deventer
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

2.  Interpretation of biphasic dissociation kinetics for isomeric class II major histocompatibility complex-peptide complexes.

Authors:  T G Anderson; H M McConnell
Journal:  Biophys J       Date:  1999-11       Impact factor: 4.033

3.  Epstein-Barr virus entry utilizing HLA-DP or HLA-DQ as a coreceptor.

Authors:  K M Haan; W W Kwok; R Longnecker; P Speck
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

4.  Inhibition of allorecognition by a human class II MHC-derived peptide through the induction of apoptosis.

Authors:  B Murphy; C C Magee; S I Alexander; A M Waaga; H W Snoeck; J P Vella; C B Carpenter; M H Sayegh
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

5.  Mapping of staphylococcal enterotoxin A functional binding sites and presentation by monoclonal antibodies and fusion proteins.

Authors:  W Mahana
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

6.  Function-related regulation of the stability of MHC proteins.

Authors:  A Simon; Z s Dosztányi; E Rajnavölgyi; I Simon
Journal:  Biophys J       Date:  2000-11       Impact factor: 4.033

7.  Structure of a covalently stabilized complex of a human alphabeta T-cell receptor, influenza HA peptide and MHC class II molecule, HLA-DR1.

Authors:  J Hennecke; A Carfi; D C Wiley
Journal:  EMBO J       Date:  2000-11-01       Impact factor: 11.598

Review 8.  Inhibition of human T-cell responses by allergen peptides.

Authors:  M Larché
Journal:  Immunology       Date:  2001-12       Impact factor: 7.397

9.  Extensive polymorphism and different evolutionary patterns of intron 2 were identified in the HLA-DQB1 gene.

Authors:  Yonggui Fu; Zehuan Liu; Jianghai Lin; Weimin Chen; Zongjian Jia; Dejing Pan; Anlong Xu
Journal:  Immunogenetics       Date:  2003-01-15       Impact factor: 2.846

10.  Crystal structure of the receptor-binding domain of human B7-2: insights into organization and signaling.

Authors:  Xuewu Zhang; Jean-Claude D Schwartz; Steven C Almo; Stanley G Nathenson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.